Chromatographic separation and mass spectrometric identification of positional isomers of polyethylene glycol-modified growth hormone-releasing factor (1-29).
Youn. Yu Seok YS; Na. Dong Hee DH; Yoo. Sun Dong SD; Song. Soo-Chang SC; Lee. Kang Choon KC
Key Findings
- A single reversed‑phase HPLC method can separate the unmodified GRF‑1‑29 and seven PEG‑GRF‑1‑29 isomers based on hydrophobic differences.
- Mass spectrometry of Lys‑C digested fragments pinpoints the exact PEG attachment sites on each isomer.
- The ability to isolate each PEG‑conjugate opens the door to testing their individual biological activity and stability.
Practical Outcomes
- For now, the study is a technical advance rather than a new dosing guide. It shows that different PEG‑attachment patterns can be isolated, which means future research may identify a PEG‑GRF version with better longevity or potency for biohackers. Until those efficacy studies are done, there’s no direct change to how you would use GRF‑1‑29.
Summary
Researchers created a simple lab test that can separate and identify all the different versions of a PEG‑attached growth hormone‑releasing factor (GRF‑1‑29) peptide. By looking at how the PEG is attached, they can tell each version apart, which will help future work on how stable and effective each version is.
Abstract
A one-step chromatographic method capable of separating all isomers of polyethylene glycol (PEG)-growth hormone-releasing factor (GRF) (1-29) conjugates was developed. The unmodified GRF (1-29) and seven different isomers of PEG-GRF (1-29) conjugates were separated by using a simple reversed-phase HPLC method depending on the differences of hydrophobicity due to the number and site of PEG attachment. The PEGylation sites of all isomers of PEG-GRF (1-29) conjugates were identified by determining the molecular masses of the Lys-C digested fragments with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. This study is a first report for the separation of all PEG-conjugate isomers and would be useful for further studies to find the promising conjugate by evaluating biological activity and stability of each isomer.
Study Information
pubmed
2004
2004-12-17T00:00:00.000Z
10.1016/j.chroma.2004.10.062